newsfilter
← Latest News
GlobeNewswire·

Sangamo Therapeutics Announces First Quarter 2026 Earnings Call

RICHMOND, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company today announced that the company has scheduled the release of its first quarter